Companies: 10,795·Total market cap: $144.5T
Isracann Biosciences Inc.

Isracann Biosciences Inc.

ISCNFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1760
P/E Ratio
52W High$0.0001
52W Low$0.00001
Overview

Isracann Biosciences Inc. (ISCNF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ISCNF · earnings · updated Jun 9, 2026

Latest Earnings

Q3 FY2022
EPS Actual
-$0.00
Revenue
Fiscal Period
Q3 FY2022
FY ends December
Report Date
Aug 31, 2022
After Market Close
ISCNF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q4 FY2024
Oct 7, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q4 FY2024
Oct 7, 2024
EPS Actual
EPS Est.
EPS Surpr.
Revenue
Q3 FY2022
Aug 31, 2022
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q2 FY2022
May 31, 2022
EPS Actual
-$0.01
EPS Est.
EPS Surpr.
Revenue
Q2 FY2022
Apr 27, 2022
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q4 FY2021
Nov 30, 2021
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q3 FY2021
Aug 31, 2021
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q2 FY2021
May 31, 2021
EPS Actual
-$0.12
EPS Est.
EPS Surpr.
Revenue
No analyst estimates available for ISCNF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q3 FY2022+23.87%
Report Date
Aug 31, 2022
EPS Beat/Miss
Price Before
$0.03
Price After
$0.04
Q2 FY2022-22.62%
Report Date
May 31, 2022
EPS Beat/Miss
Price Before
$0.07
Price After
$0.05
Q2 FY2022+20.91%
Report Date
Apr 27, 2022
EPS Beat/Miss
Price Before
$0.05
Price After
$0.06
Q4 FY2021-6.49%
Report Date
Nov 30, 2021
EPS Beat/Miss
Price Before
$0.07
Price After
$0.06
Q3 FY2021-3.61%
Report Date
Aug 31, 2021
EPS Beat/Miss
Price Before
$0.08
Price After
$0.08
Q2 FY2021+5.88%
Report Date
May 31, 2021
EPS Beat/Miss
Price Before
$0.19
Price After
$0.20
Q1 FY2021-0.08%
Report Date
Feb 28, 2021
EPS Beat/Miss
Price Before
$0.29
Price After
$0.29
Q4 FY2020+13.05%
Report Date
Nov 30, 2020
EPS Beat/Miss
Price Before
$0.19
Price After
$0.22
Beat Rate0 / 8 quarters
Largest Move+23.87% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: ISCNF ends December

Isracann Biosciences Inc. (ISCNF) most recently reported earnings on August 31, 2022 for Q3 FY2022, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ISCNF earnings date is expected around September 1, 2026.

Each quarter, investors track ISCNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ISCNF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ISCNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

ISCNF earnings · 4 questions

Isracann Biosciences Inc.'s next earnings report is expected around September 1, 2026. ISCNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ISCNF historically reports after market close (AMC).

ISCNF earnings datewhen is ISCNF earningsISCNF next earnings datewhen does ISCNF report earningsISCNF earnings calendar

Source: FMP · Isracann Biosciences Inc. SEC filings · US GAAP · Isracann Biosciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026